Latest Insider Transactions at Avita Medical, Inc. (RCEL)
This section provides a real-time view of insider transactions for Avita Medical, Inc. (RCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AVITA Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AVITA Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2024
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
975
+2.03%
|
$11,700
$12.47 P/Share
|
|
Nov 29
2024
|
David D O'Toole CFO |
BUY
Grant, award, or other acquisition
|
Direct |
785
+3.33%
|
$5,495
$7.83 P/Share
|
|
Aug 19
2024
|
Robert Mc Namara |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+21.86%
|
$90,000
$9.0 P/Share
|
|
Jun 05
2024
|
Lou Panaccio |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+16.55%
|
-
|
|
Jun 05
2024
|
Suzanne Crowe |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+20.16%
|
-
|
|
Jun 05
2024
|
Jeremy Curnock Cook |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+23.58%
|
-
|
|
Jun 05
2024
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+18.33%
|
-
|
|
Jun 05
2024
|
Robert Mc Namara |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+26.32%
|
-
|
|
Jun 05
2024
|
Cary Guy Vance |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+26.32%
|
-
|
|
May 31
2024
|
Donna Shiroma General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,225
+4.62%
|
$17,800
$8.17 P/Share
|
|
May 31
2024
|
David D O'Toole CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,240
+9.25%
|
$17,920
$8.17 P/Share
|
|
May 30
2024
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+2.5%
|
$8,000
$8.9 P/Share
|
|
Feb 28
2024
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
1,250
+3.22%
|
$21,250
$17.41 P/Share
|
|
Dec 26
2023
|
James Corbett CEO |
SELL
Open market or private sale
|
Direct |
1,445
-11.09%
|
$18,785
$13.29 P/Share
|
|
Dec 13
2023
|
Jeremy Curnock Cook |
SELL
Open market or private sale
|
Direct |
2,518
-10.89%
|
$30,216
$12.27 P/Share
|
|
Dec 12
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
950
+5.15%
|
$11,400
$12.45 P/Share
|
|
Dec 01
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
500
+2.94%
|
$5,000
$10.68 P/Share
|
|
Nov 30
2023
|
Donna Shiroma General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,469
+3.25%
|
$13,221
$9.06 P/Share
|
|
Nov 30
2023
|
David D O'Toole CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,034
+6.06%
|
$9,306
$9.06 P/Share
|
|
Nov 21
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+6.46%
|
$20,000
$10.28 P/Share
|
|
Nov 16
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+7.69%
|
$12,000
$12.15 P/Share
|
|
Nov 15
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+7.74%
|
$24,000
$12.85 P/Share
|
|
Nov 14
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+9.09%
|
$12,000
$12.88 P/Share
|
|
Aug 21
2023
|
Donna Shiroma General Counsel |
SELL
Open market or private sale
|
Direct |
4,193
-9.03%
|
$62,895
$15.84 P/Share
|
|
Aug 16
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+10.56%
|
$34,000
$17.05 P/Share
|
|
Aug 15
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+17.69%
|
$85,000
$17.93 P/Share
|
|
Jun 20
2023
|
David D O'Toole CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+33.33%
|
$16,000
$16.15 P/Share
|
|
Jun 06
2023
|
Cary Guy Vance |
BUY
Grant, award, or other acquisition
|
Direct |
16,549
+38.59%
|
-
|
|
Jun 06
2023
|
Robert Mc Namara |
BUY
Grant, award, or other acquisition
|
Direct |
16,549
+38.59%
|
-
|
|
Jun 06
2023
|
Lou Panaccio |
BUY
Grant, award, or other acquisition
|
Direct |
6,175
+14.23%
|
-
|
|
Jun 06
2023
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
6,175
+16.27%
|
-
|
|
Jun 06
2023
|
Jeremy Curnock Cook |
BUY
Grant, award, or other acquisition
|
Direct |
6,175
+21.08%
|
-
|
|
Jun 06
2023
|
Suzanne Crowe |
BUY
Grant, award, or other acquisition
|
Direct |
6,175
+18.49%
|
-
|
|
Dec 12
2022
|
Jeremy Curnock Cook |
BUY
Grant, award, or other acquisition
|
Direct |
12,589
+42.63%
|
-
|
|
Dec 12
2022
|
Suzanne Crowe |
BUY
Grant, award, or other acquisition
|
Direct |
12,589
+37.42%
|
-
|
|
Dec 12
2022
|
Lou Panaccio |
BUY
Grant, award, or other acquisition
|
Direct |
12,589
+28.86%
|
-
|
|
Dec 12
2022
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
12,589
+32.95%
|
-
|
|
Nov 21
2022
|
Michael S Perry Director |
SELL
Open market or private sale
|
Direct |
150,000
-39.52%
|
$1,050,000
$7.18 P/Share
|
|
Nov 21
2022
|
Michael S Perry Director |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+28.33%
|
$750,000
$5.99 P/Share
|
|
Sep 01
2022
|
Michael S Perry Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,980
+0.98%
|
-
|
|
Jul 01
2022
|
Michael Holder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,950
+43.63%
|
-
|
|
Jul 01
2022
|
Erin Liberto Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,950
+43.63%
|
-
|
|
Jul 01
2022
|
Kathy M. Mc Gee Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,950
+43.63%
|
-
|
|
Jul 01
2022
|
Andrew Quick Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,950
+43.63%
|
-
|
|
Jul 01
2022
|
Donna Shiroma General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
35,950
+43.63%
|
-
|
|
Jun 01
2022
|
Michael S Perry Director |
SELL
Other acquisition or disposition
|
Direct |
23,754
-7.38%
|
-
|
|
Feb 24
2022
|
Michael S Perry Director |
SELL
Open market or private sale
|
Direct |
10,812
-3.25%
|
$86,496
$8.74 P/Share
|
|
Feb 23
2022
|
Michael S Perry Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,713
+4.27%
|
-
|
|
Dec 22
2021
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
13,025
+37.52%
|
-
|
|
Dec 22
2021
|
James Corbett CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,025
+37.52%
|
-
|